ClinicalTrials.Veeva

Menu

Metabolic Imaging of Neurological Disease (MIND)

University of Oxford logo

University of Oxford

Status

Invitation-only

Conditions

Multiple Sclerosis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Multiple Sclerosis is a chronic condition that shows changes in the way that the brain consumes sugar. It is also known that there are a number of metabolic and inflammatory sequelae following a transient ischemic attack/stroke (hereby referred to collectively as 'stroke'). This study will use a powerful new technology ('hyperpolarised magnetic resonance imaging') to detect these changes in the brains of people with multiple sclerosis and Clinically Isolated Syndrome (CIS) or following a stroke when compared to a group of healthy volunteers. It will be undertaken at the University of Oxford, and each participant will undergo up to 4 scans over the course of three years.

Enrollment

250 estimated patients

Sex

All

Ages

Under 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosis of MS or stroke

Exclusion criteria

Trial design

250 participants in 1 patient group

Multiple Sclerosis
Description:
All phenotypes

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems